← FDA Drug Approvals (Drugs@FDA)

ABRILADA

BLA · Biologics License Application · Sponsor: PFIZER INC · Approved 2019-11-15

Drug application

FDA Application #
BLA761118
Application type
Biologics License Application
Brand name
ABRILADA
Generic name
ADALIMUMAB-AFZB
Active ingredients
ADALIMUMAB-AFZB
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
PFIZER INC
Manufacturer
Pfizer Laboratories Div Pfizer Inc
First approval
2019-11-15

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown